Table 4.
Meta-regression summary of study-level factors associated with LVSD
| Variable | Studies (n) | Co-efficient | SE | Z | OR | 95% CI | p-value | Interpretation |
|---|---|---|---|---|---|---|---|---|
| ART % (per 10% increase) | 17 | -0.29 | 0.11 | -2.58 | 0.75 | 0.60–0.93 | 0.01 | Higher ART coverage associated with lower LVSD prevalence |
| AIDS % (per 10% increase) | 13 | -0.30 | 0.18 | -1.65 | 0.74 | 0.52–1.06 | 0.10 | No significant relationship |
| ART era (pre-ART REF) | 20 | -2.31 | 0.62 | -3.75 | 0.10 | 0.03–0.33 | < 0.001 | Significant reduction in LVSD in the ART era |
| Echocardiographic method (EF REF) | 19 | 2.16 | 0.48 | 4.46 | 8.67 | 3.35–22.38 | < 0.001 | FS yields higher prevalence estimates |
| Study quality (moderate REF) | 20 | -1.79 | 0.64 | -2.80 | 0.17 | 0.05–0.58 | 0.005 | Higher-quality studies report lower prevalence |